ABSTRACT
Introduction
Tobacco consumption is a global health problem; it is considered a pandemic involving 1.3 billion people. In Brazil, the prevalence of tobacco consumption is 14.7%. Tobacco smoke was responsible for 6 million deaths per 1
One of the deleterious effects of smoking is wound healing complications.
Tobacco-exposure increases three times the rate of complications in wound Healing when Compared to a health patient 2, 3 .
For this reason, several strategies were studied to decrease surgical complications [4] [5] [6] , one of the strategies was to use BontA as a vasodilator [7] [8] [9] .
We examined the effect of BontA in healthy rats, diabetic rats and, in rats exposed to smoke for 28-days, for the viability of skin flaps. Although BontA showed a difference in health and diabetic animals, there was no BontA effect in the flap viability for the tobacco-exposed group 9 . This hypothesis was based on other studies 10, 11 . These studies showed a paradoxical increase of bronchodilation by using botulinum toxin type A (BontA) in a short time exposure to tobacco. Considering our previous study and the controversial results In the literature, we decided to test the effect of BontA in random flap for different smoke exposure periods.
Methods
The protocol was approved by the Ethics Committee of the Medical School, Universidade de São Paulo (028/2014).
All procedures strictly followed current regulations related to animal experimentation dictated by the Council for International
Organization of Medical Sciences, ethical code for animal experimentation. All animals were submitted to 24h night/day cycles, water and chaw ad libitum.
Sixty Wistar rats were used, 2-month old, and weighing 250-300g. These animals were divided into two groups; 
Tobacco exposure
The animals were exposed in a 28-L plastic box with three orifices: on the inlet for synthetic air (2 L/min); another for smoke; and, an outlet to ventilate the excessive smoke. The smoke inlet was connected to a Venturi system controlled by means of fluxometry (2.5 L/min),which was connected to a lit cigarette.
Carbon monoxide (CO) was monitored using a single gas detector (ToxiPro; Biosystems, USA) to maintain a CO concentration of 300-350 ppm (parts per million) inside the box.
At the end of the group exposure period, all animals were submitted to a random dorsal cutaneous flap (3 x 10cm).
BontA/ saline solution injection
Seven days before the surgical procedure, all animals were anesthetized with intraperitoneal ketamine (100mg/Kg) and xylazine (5mg/Kg). The torso was trichotomized and we designed a 3x10cm flap. According to the subgroup, we injected (intradermal) 0.02ml of BoNTA/puncture, a total of 20u/rat (Botox ® 100u, Allergan. Irvine. CA. USA) or the same volume of saline solution. The puncture scheme was 2 rows of 10 puncture points (1cm apart).
Surgical procedure
Antisepsis was performed using 0.5% chlorhexidine.
Under inhaled anesthesia (20% isoflurane; 150-200 ml/min) the 3×10cm cranial flap based on the scapulae was elevated. The flap was then returned to its original position and sutured using separate stitches of 4-0 mononylon. Seven days after surgery, the rats were euthanized by anesthetic overdose (ketamine 200 mg/kg).
Flap area analysis
Immediately before euthanasia the flaps were photographed (Olympus 3.5mm digital camera; Olympus Stylus ® , Japan) with a ruler along the length of the flap. The total area of the flap and the necrosis area were measured (squared millimeters) using the ImageJ ® software. The viable skin was defined as pink, warm, and soft to touch. Necrotic areas were defined as brown-toblack, cold, and hard to touch. Then we calculated the percentage of healthy skin area (Survival area).
Carboxyhemoglobin analysis
At the end of the experiment, all animals were euthanized by anesthetic overdose (ketamine 200 mg/kg).
Immediately after euthanize, we punctuated the heart of all animals for blood collection. We measured carboxyhemoglobin by ABL radiometer (Radiometer Medical Aps, BronshojDinamarca)
Statistical analysis
Performed 
Results
Nine animals did not survive: five (two in group1, and three in group 4) died due to anesthesia; and four animals due to diarrhea (one in group 3 and three in group 2) ( Table 1) . While searching for data in the literature, we identified studies about the paradoxical effect of tobacco in bronchiolar physiopathology. In a short period of tobacco-exposure the bronchia dilated but in a long-term exposure (more than 30days), the bronchia contracted. This piece of information suggested that we should test two-and four-month of tobacco exposure effect on the viability of cutaneous flap 10, 11 .
Moreover, there was no difference in terms of flap viability between health (no exposure) and smoke-exposure animals in this previous study 9 . We hypothesized that the 3x10cm flap would cause a very severe vascular insufficiency resulting in necrosis, and that no additional deleterious environmental factor (tobacco-exposure) would increase necrosis. For this reason, we decided to inject a vasodilator (BontA), to evaluate the effect of two different time exposure regimens in flap viability.
According to our results, we showed that 2-and 4-month exposure regimens were adequate to produce vascular alterations that could benefit from vasodilator use (ratio = 0.61, p=0.04 and ratio= 0.71, p=0.01, respectively).
Additionally, there was no difference in flap viability for
BontA groups related to exposure time (subgroups comparing 2 and 4months, p=0.16).
Comparing to literature data, most studies injected nicotine to evaluate strategies to improve flap viability. However, to reproduce a clinical condition, we believe that nicotine injection was inadequate. The cigarette had more than one thousand of substances that can interfere with flap survival, and for this reason we adopted this model 12 .
Few exposure rat models were used in experimental studies. Nolan et al. 14 , showed a mainstream exposure model. These authors exposed rats during a 28-day period and evaluated flap viability. The flap dimensions were 2.5x10cm and after 28 days of tobacco exposure, the necrosis was 78.2%. Necrosis found in our study was different for several reasons; one reason was the flap dimensions (2.5x10cm versus 3x10cm Moreover, it was difficult to reproduce the equipment used in Nolan et al. 14 , thus, we adopted the model of Biselli et al because it was a feasible and reproducible equipment 12, 14 . We consider these results methodological steps to define this tobacco exposure model as feasible and reproducible. Our study had some limitations; we did not assess the pathophysiology of tobacco smoke exposure. It would be important for next projects to study this outcome. Random cutaneous flap is routinely used in plastic surgery, but new studies must perform axial and composite flaps. More studies about pathophysiology and other therapeutic strategies should be done.
Conclusions
Botulinum Toxin A increased random flap viability in tobacco-exposed rats. Two months of tobacco exposure had the same effect as four months of exposure.
